Trial intelligence / Profile preview

Therapeutic effect of platelet-rich plasma (PRP) on ovarian function in poor responders

IRCT20181216042006N2Phase 2Completed

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
Feb 2023
Countries
1
01

Overview

Phase 2, single-arm trial of platelet-rich plasma in poor ovarian response (POR), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Started Feb 2023; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

poor ovarian response (POR)

Beyond the preview

Go deeper on IRCT20181216042006N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181216042006N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call